Featured
Company announces another leadership change
There's more shuffling in this leadership team, with news the company head is to be replaced next year by someone whose history with the organisation runs just as deep
Industry & Companies
Astellas turns up the heat on politicians
Temperatures were high when three Sydney MPs visited the pharma's Macquarie Park office. Find out why
Leadership & People
Pharma exec shares life lessons after horror bus crash
National Sales Manager Sharyn Junkeer shares the lessons she's painfully learned about life and career after suffering critical injuries in a horror bus crash
Jobs & Workplace
Farewells dominate Aussie pharma job moves
Departures from companies, Australia and even industry have dominated the latest round of job moves across pharma
Pipeline & Intellectual Property
Secret data leak, landmark results... then a share tumble
Over a tumultuous few hours, impressive data on the world's first mRNA cancer vaccine was leaked, then praised, before a tumble on the stock market
Featured
Ex-Aussie GM nabs top job with newcomer
This well-known boss is back in Australia and leading the region for a company that's chasing approvals globally for a drug that's been hailed a game-changer
Regulatory & Reimbursement
PBAC-ticked gene therapy wins TGA nod
A new form of a gene therapy expands the indicated population to catch those who weren't diagnosed in time
Leadership & People
Pharma boss smashes two glass ceilings
Inducted into the Hall of Fame as a "pioneer of breaking glass ceilings" in both gender and age, this pharma leader has been honoured for her vision and courage
Industry & Companies
Arrotex signs deal for locally-developed med
Agreement brings together innovative anti-infective development platform and the Aussie giant's established regulatory, market access and commercial capabilities
Awards
LinkedIn names Australia's best workplaces
Healthtech has emerged as a major force in this year’s LinkedIn Top Startups Australia list, an annual ranking of the emerging companies where professionals want to work
Pipeline & Intellectual Property
Aussies tapped for US gene project
UQ researchers selected to help the US produce personalised genetic therapies in hospitals to deliver RNA medicines to patients within days of diagnosis, instead of months
Latest
BioNTech opens Aussie mRNA facility
World-class facility in Melbourne will help deliver the next generation of life-changing treatments in cancer, heart disease, and neurological and autoinflammatory diseases
Government & Policy
Australia's long road to closing CAR T gap
Funding CAR T treatments isn't enough when structural barriers prevent the majority of referrals from accessing CAR T.
Regulation & Legal
CSL slapped with investor class action
A lawsuit has been filed by investors who bought shares during a calamitous price plunge but CSL has promised to 'vigorously' defend all accusations
Jobs & Workplace
Feeling disengaged? Here's what might be missing
An industry survey has uncovered the most important motivator for workplace engagement with more than 2300 open-ended comments pointing to one must-have
Industry & Companies
Time-poor doctors move from papers to podcast
An Australian company is helping time-poor doctors stay up to speed with the latest research by turning clinical papers into podcasts with pharmas on board as sponsors
Industry & Companies
Takeover sends shares tumbling by 34%
This ASX-listed company has increased its stake to own two-thirds of a joint venture started two years ago but investors are not impressed
Industry & Companies
Aussie industry mega-event in full swing
Three flagship events brought together by AusBiotech for the first time is underway on the Gold Coast with more than 2500 expected to attend
Featured
CSL names ex-Aussie GM as new CEO
After a global search, CSL has picked a former Aussie GM and a 'world-class, purpose-driven' high-flyer from a rival pharma to be its fourth CEO
Popular
Can doctors be bought for the price of a sandwich?
The more free meals a doctor receives from pharma, the more likely they are to prescribe less appropriate or more expensive drugs, according to a new review
Patients
Aussie patient groups speak up on pricing
New website reveals that Australian patients are among the most active in the world when it comes to taking their case for medicines access to drug-pricing regulators
Regulatory & Reimbursement
15 drugs jostle for November PBS listings
Among the 15-strong list are nine drugs vying to become the first to secure subsidy after being recommended at the PBAC's July 2026 meeting
Industry & Companies
Bots move in at pharma logistics base
DHL has introduced advanced automation as part of a $9 million upgrade of its pharma facility in South-West Sydney
Jobs
-
Territory Manager - Surgical Devices New
-
Commercial Excellence Analyst New
-
Territory Manager New
-
Senior Procurement & Planning Specialist New
-
Principal Investigator - Clinical Research | Clinical Trials Doctor New
-
Pharmaceutical Sales Representative New
-
Pharmacovigilance Manager New
-
Senior Territory Manager - Pharmacy QLD New
-
Warehouse Assistant & Forklift Driver New
-
Territory Manager New
Government & Policy
Trump splurges on Big Pharma shares
The US President has come under scrutiny after boosting his pharma shareholdings by a breathtaking 3000 per cent last year. Find out which companies he's invested in
Regulatory & Reimbursement
PBAC tweaks November Agenda
One submission withdrawn, a couple of newcomers join the list and a potentially eye-opening DUSC analysis deferred as PBAC readies for its next meeting in a fortnight
Regulatory & Reimbursement
Rare disease drugs head for Australia
The TGA has handed out eight orphan drug designations in the past quarter, with three of them targeting the same kidney disease.
Industry & Companies
Roche stakes $22B bet on Chinese ADCs
The deal sees Roche take over late stage development and gain ex-China marketing rights for a range of ADCs.
Industry & Companies
Who's scored a seat on the Medicines Australia Board?
Medicines Australia has named two high-profile company leaders as the newest additions to the Board, after Country Leadership changes mid-year resulted in departures
Regulatory & Reimbursement
Sept PBAC: Winners and Losers
Two out of three companies hoping to cut a path to a broad listing were told the preliminary info they provided didn't cut it, according to outcomes from September's Intracycle Meeting
- Government & Policy Is it time for pharma to boycott PBAC?
- Regulatory & Reimbursement Second generic targets $113M drug
- Regulation & Legal Counter-claim alleges false advertising by accuser
- Industry & Companies How much do pharmas earn in Australia?
- Regulation & Legal HCP bungles trigger updates to two vaccine PIs
- Regulatory & Reimbursement If you want a broad listing, ask the patients
- Industry & Companies Pharmas go on $11B buying binge
- Regulation & Legal Troubled $33M drug withdrawn from Australia
- Other News Leader flies a new flag for industry
- Pipeline & Intellectual Property Roadblock hits plans to shore up the world's biggest drug